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Objective. To evaluate evidence of practice changes affecting kidney transplant pro-
gram volumes, and donor, recipient and candidate selection in the era surrounding the
introduction of Centers for Medicare and Medicaid Services (CMS) conditions of
participation (CoPs) for organ transplant programs.
Data. Scientific Registry of Transplant Recipients; CMS ESRD and Medicare claims
databases.
Design. Retrospective analysis of national registry data.
Methods. A Cox proportional hazards model of 1-year graft survival was used to
derive risks associated with deceased-donor kidney transplants performed from 2001
to 2010.
Findings. Among programs with ongoing noncompliance with the CoPs, kidney
transplant volumes declined by 38 percent (n = 766) from 2006 to 2011, including a 55
percent drop in expanded criteria donor transplants. Volume increased by 6 percent
(n = 638) among programs remaining in compliance. Aggregate risk of 1-year graft
failure increased over time due to increasing recipient age and obesity, and longer
ESRD duration.
Conclusions. Although trends in aggregate risk of 1-year kidney graft loss do not indi-
cate that the introduction of the CoPs has systematically reduced opportunities for mar-
ginal candidates or that there has been a systematic shift away from utilization of higher
risk deceased donor kidneys, total volume and expanded criteria donor utilization
decreased overall among programs with ongoing noncompliance.
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The Centers for Medicare and Medicaid Services (CMS) is the largest single
payer of transplant services in the United States, and it approves transplant
programs that receive Medicare reimbursement. In March 2007, CMS
published as a final rule in the Federal Register conditions of participation
(CoPs) for organ transplant programs. These CoPS establish requirements for
the approval and re-approval of transplant centers; programs not attaining
specified 1-year post-transplant patient and graft survival rates risk loss of
Medicare approval for reimbursement (Centers for Medicare and Medicaid
Services 2007). Transplant programs are required to report candidate and reci-
pient information to the Organ Procurement and Transplantation Network
(OPTN). These data are analyzed by the Scientific Registry of Transplant
Recipients (SRTR) and subsequently published at http://www.srtr.org in
bi-annual program-specific reports (PSRs). PSR outcomes are generated
based on rolling 2½-year cohorts of patients and include 1-year observed and
expected outcomes; that is, the number of events expected for that program
based on national averages and adjusted for the casemix of the program. The
specific tolerance limits set by CMS are as follows: 1-year observed patient
deaths or graft failures exceeding expected values by 50 percent, an absolute
difference in the number of observed (actual) versus expected adverse events
(patient deaths or graft failures) in excess of 3, and a statistically significant dif-
ference between observed and expected events (one-sided t-test; p < .05)
(Hamilton 2008). PSRs are monitored by CMS, private insurers, and the
public for outcomes that might indicate potential quality or safety issues.
The implication of risk adjustment methodology for the fair appraisal of
program performance is a subject of ongoing debate (Abecassis et al. 2009;
Howard, Cornell, and Schold 2009; Axelrod 2013). Although the SRTR case
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mix adjustment is comprehensive for donor-and recipient-related factors, it is
not possible, and indeed not the intent of the SRTR and regulators, to exhaus-
tively account for all determinants of patient and graft outcomes when evaluat-
ing program outcomes. A related concern is that the focus on outcomes as a
requirement for CMS approval, combined with a lack of confidence in the
adequacy of SRTR risk adjustment, may have prompted some programs to
modify their organ and candidate selection criteria based on the perception
that more conservative practices in the acceptance of donor organs and selec-
tion of recipients may allow them to avoid citation (Weinhandl et al. 2009;
Schold, Arrington, and Levine 2010). In aggregate, such practices would likely
have the unintended consequences of disadvantaging higher risk transplant
candidates and potentially reducing overall transplant volumes.
We evaluated the evidence for practice changes affecting kidney trans-
plant volumes, wait-listing decisions, organ acceptance, and recipient selec-
tion in the era surrounding the introduction of the CoPs. We examined trends
in kidney transplantation only because this involves the greatest number of
recipients and is performed at nearly all transplant centers. Furthermore, one
of the most important trends in organ transplantation over the past decade has
been the utilization of expanded criteria donor (ECD) kidneys (Port et al.
2002), and we explore evidence of changing utilization of ECD kidneys in the
years subsequent to the implementation of the CoPs. In the absence of qualita-
tive data detailing each program’s reaction to the CoPs, we focused on prac-
tices subsequent to the first SRTR outcomes flag recorded after the CoPs came
into effect. We hypothesized that those programs with SRTR-reported out-
comes exceeding case mix–adjusted tolerance limits on one or more occasions
would be the most likely to exhibit risk-averse practices affecting volumes and
selection with respect to candidates, recipients, and donors.
METHODS
Data and Sources
Data were from the SRTR database (candidate, recipient, and donor charac-
teristics; program transplant outcomes; and derived compliance with CoPs/
flagging history), and CMS ESRD and Medicare claims databases (ESRD
patient demographics, clinical characteristics at initiation of maintenance
hemodialysis or preemptive kidney transplantation; Medicare claims, includ-
ing those for dialysis and hospitalization; and death dates). These data were
enhanced by cross-referencing the Social Security Death Master File for
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additional ascertainment of dates of death not reported by transplant pro-
grams, and by inclusion of Census Data on Income by ZIP code (http://www.
melissadata.com/products/zip-data.htm). The same average income, as avail-
able from the last census update ( January 2002), was used for each patient in
each year of the period under study, so that any trends with respect to average
income over time could be attributed to changes in patient mix, independent
of economic trends. All programs with an adult kidney PSR for July 2007 that
performed at least one adult kidney transplant in 2007 were included in the
present analysis (N = 221). Combined kidney-pancreas transplants were
excluded from the analysis (other multiorgan kidney transplants were
included).
Definitions
Kidney transplant programs were grouped according to their SRTR-reported
performance with respect to graft outcomes subsequent to the implementation
of the CoPs. Four groups of programs were identified based on outcomes
reported in PSRs released between July 2007 and July 2012:
Never flagged: programs that were not flagged for outcomes in any of the
PSRs over the period from July 2007 to July 2012; n = 142.
Single flag ( July 2007 to July 2009): programs that were flagged for out-
comes in only one of the first five PSRs released after the CoPs came into
effect ( July 2007, January 2008, July 2008, January 2009, or July 2009);
n = 16.
Multiple flags ( July 2007 to July 2009), returned to compliance: programs
that were flagged for outcomes in two or more of the first five PSRs released
after the CoPs came into effect but were not flagged in any subsequent
PSRs released between July 2009 and July 2012; n = 14.
Ongoing noncompliance ( July 2007 to July 2012): programs that were
flagged for outcomes in two or more of the first five PSRs released after the
CoPs came into effect, and also received one or more additional flags
between July 2009 and July 2012; n = 26.
These groups emphasize outcomes during the first 2 years following the
implementation of the CoPs in order to maximize the follow-up period over
which to observe practice changes. Programs that received their first outcomes
flag after July 2009 were excluded from the main analyses, given the shorter
follow-up period over which to observe any changes in practice subsequent to
flagging (n = 23). Programs that closed at any point after July 2007 were
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included in the analysis, contributing data up to and including the year they
closed (in years subsequent to closure, transplant volume is set to zero;
n = 13). Programs that voluntarily withdrew from Medicare between July
2007 and July 2012 (n = 5) were included in the analysis prior to and subse-
quent to their withdrawal. The reasoning for this approach was that volume
loss as a result of any program closure, or subsequent to withdrawal from
Medicare, is a natural consequence of the regulatory process and relevant to
the wider question of whether shifts in program practices have occurred since
the introduction of the CoPs.
Analysis of Donor, Recipient, and Transplant Risk
Risks of 1-year graft failure associated with donor, recipient, and transplant
characteristics were estimated for all deceased donor kidney transplants per-
formed among recipients ≥18 years of age during the period under study. The
donor-related risk burden was assessed according to all covariates in the
OPTN Donor Profile Index: age, black race, creatinine >1.5, hypertension,
diabetes, stroke, height, weight, HCV status, DCD status, and cause of death
(Organ Procurement and Transplant Network (OPTN) 2012);. Recipient-
related risk was estimated according to all recipient-related covariates in the
SRTR (PSR) risk adjustment model ( January 2012), which included previous
solid organ transplant, age, gender, race, BMI, recipient diagnosis of diabetes,
recipient diagnosis of hypertension, recipient diagnosis of other vascular dis-
ease, HCV status, peak PRA, preemptive transplantation, year of ESRD treat-
ment, and insurance status (Scientific Registry of Transplant Recipients
(SRTR) 2012). The overall burden of risk associated with transplantation was
assessed according to all covariates in the SRTR risk adjustment model,
including the donor and recipient factors listed above plus cold ischemia time,
pulsatile perfusion, organ shared outside DSA, and HLAmismatch (Scientific
Registry of Transplant Recipients (SRTR) 2012).
Risks of 1-year graft failure were estimated by applying to each individ-
ual adult deceased-donor kidney transplant performed between 2001 and
2011, and to each newly wait-listed adult candidate, the survival model effects
(betas) associated with donor, recipient, and transplant characteristics. This
was done by multiplying the characteristics of the donors, recipients, and
transplants by their respective effects (betas) and summing the linear combina-
tion. The covariate betas calculated by SRTR for the January 2012 wave of
PSRs were applied (Scientific Registry of Transplant Recipients [SRTR] 2012)
and are based on outcomes of deceased donor kidney transplants performed
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between July 2008 and January 2010. Average program risks attributable to
donor/recipient/transplant factors within each calendar year were calculated
as the total program risk for that year, divided by the total number of trans-
plants performed by the program in that year. Change over time in risk was
calculated as the average program risk in each year divided by the average
national risk attributable to donor/recipient/transplant factors in 2007. Aver-
age risks of 1-year graft failure within program groups (i.e., never flagged, sin-
gle flag etc.) were calculated with weighting for program size (i.e., each group
was treated as one large program), to better reflect the scale of any systematic
shift away from high-risk donors or recipients. To evaluate the statistical signif-
icance of shifts in aggregate risk over time, linear trend tests were conducted.
Individual (patient-level) risks were regressed against year within each pro-
gram performance group, and the beta coefficient for year tested for a linear
association with risk.
Finally, a sensitivity analysis was conducted, calculating unweighted
risks of 1-year graft failure for each program group to determine whether
weighting had a qualitative effect on the results. All analyses were performed
in SAS Version 9.2. p-values for the difference between groups with respect to
prevalence of individual donor, recipient, and transplant characteristics were
calculated by Pearson’s chi-squared test for equivalent proportions.
RESULTS
The total number of kidney transplants performed by the 221 adults programs
included in the present analysis fell from a high of 16,109 in 2006, to 15,764 in
2011 (Medicare CoPs for organ transplant programs were implemented in
mid 2007). A reduction in volume from 2,013 transplants performed in 2006
to 1,247 transplants performed in 2011 was observed for the group of programs
with ongoing noncompliance (average decline of 30 kidney transplants per
program over this interval, or 38 percent of total volume). Smaller reductions in
volumes were observed for the group of programs with a single flag (918 trans-
plants in 2006 vs. 862 transplants in 2011, average 5-year decline of 3.5 trans-
plants per program, or 6 percent), and for the group of programs that received
multiple flags but returned to compliance (1,046 transplants in 2006 vs 1,032
transplants in 2011, average 5-year decline of 1 transplant per program, or 1 per-
cent). In contrast, total kidney transplant volumes increased among programs
that were never flagged, from 10,492 transplants in 2006 to 11,130 transplants
in 2011 (average per program increase of 4.5 transplants, or 6 percent).
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Compared to the number of transplants performed in the 12 months
leading up to their first PSR flag after the CoPs came into effect, 2–3 years
after this first flag the 16 programs with a single flag performed 33.3 percent
fewer standard criteria donor (SCD) kidney transplants, 26.3 percent fewer
living donor kidney transplants, 32.3 percent fewer ECD kidney transplants,
and 34.7 percent fewer donors after circulatory death (DCD) kidney trans-
plants (Figure 1). The 14 programs that received multiple flags but returned to
compliance performed a total of 10.0 percent fewer SCD, 3.4 percent more
living donor, 33.9 percent more ECD, and 123 percent more DCD trans-
plants 2–3 years after their first flag. The 26 programs with ongoing noncom-
pliance performed a total of 21.1 percent fewer SCD, 28.5 percent fewer living
donor, 55.1 percent fewer ECD, and 6.8 percent more DCD transplants
2–3 years after their first flag. By comparison, the 142 programs that were
never flagged for outcomes performed 3.3 percent fewer SCD, 6.2 percent
more living donor, 4.2 percent more ECD, and 31.0 percent more DCD trans-
plants over the same interval. The relative utilization of ECD kidneys (the pro-
portion of all kidney transplants derived from ECDs) remained fairly
consistent across all performance groups (Figure 2), only showing a consistent
decline among programs with ongoing noncompliance. In this group of
programs, ECD utilization fell from 12 percent at 0–1 years prior to first out-
comes flag to 8 percent at 2–3 years after first flag.
Table 1 shows the prevalence of individual donor, recipient, and trans-
plant-related risk factors within each group of programs, at time points
2–1 years pre- versus 1–2 years post first outcomes flag (or July 2005/July
2006 vs July 2008/July 2009 for never-flagged programs). The proportion of
donors with diabetes increased among all program groups, as did the propor-
tion of donors with serum creatinine >1.5. For the group of programs that were
never flagged, the proportion of donors that were aged older than 60 years or
DCD also increased significantly. Among programs that received multiple
flags between July 2007 and July 2009 but subsequently returned to compli-
ance, the proportion of donors who were black, had hypertension, died of
stroke, or were DCD all significantly increased. The proportion of DCDs also
increased significantly among programs with ongoing noncompliance; how-
ever, the proportion of donors who were aged >60, black, had hypertension,
died from stroke, or were ECD declined. Despite significant variation in the
proportion of donors with diabetes or hypertension at 2–1 years pre first flag
( July 2005/July 2006 for never-flagged programs), the prevalence of these risk
factors was not statistically different across each flagging group by 1–2 years
post first flag (or July 2008/July 2009).
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With respect to recipient-related factors, the prevalence of age >60,
ESRD >2 years, and BMI ≥30 kg/m2 increased over time across all flagging
groups. Among programs that were never flagged, the proportion of recipients
who were black, had a diagnosis of hypertensive nephropathy, or a PRA ≥80
also increased significantly ( July 2005/July 2006 vs. July 2008/July 2009).
Similar shifts in recipient characteristics were observed for the group of
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Figure 1: Percentage Change in Aggregate Transplant Volume, by Organ
Type, Relative to Year Prior to First Outcomes Flag (Time Zero, Indicated by
the Vertical Line); for Programs That Were Never Flagged, Percentage
Change Is Calculated Relative to Kidney Transplant Volume in the Twelve
Months from July 2006 to July 2007
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programs that received multiple flags but returned to compliance. At time
points both pre- and post-first flag, the group of programs with ongoing non-
compliance transplanted the highest proportion of recipients who had a pri-
mary diagnosis of diabetic or hypertensive nephropathy, or an ESRD
duration of ≥2 years, and the lowest proportion of recipients with private
insurance as their private insurance type. At 2–1 years prior to first flag ( July
2005/July 2006 for never-flagged programs), there was significant variation
between flagging groups in the prevalence of recipients who were aged >60,
black, recipients of a previous transplant, had a primary diagnosis of diabetic
nephropathy or hypertensive nephropathy, an ESRD duration ≥2 years,
BMI ≥30 kg/m2, and in the proportion of recipients with private insurance as
their primary insurance type. By 1–2 years post-first flag (or July 2008/July
2009), disparities between groups in the prevalence of older recipients and the
proportion who had received a previous transplant were no longer significant.
With respect to transplant-related risk factors, there was significant heteroge-
neity in the prevalence of organs shared outside the OPO, but, in general, the
proportion of organs that were shared declined over time across flagging
groups. The proportion of pumped kidneys and non-zero HLA mismatch
transplants increased over time in all groups.
Table 2 shows trends in the prevalence of selected clinical and demo-
graphic characteristics for candidates newly wait-listed for kidney transplanta-
tion, prior to and subsequent to first outcomes flag (or July 2005/July 2006 vs.
July 2008/July 2009 for never-flagged programs). The prevalence of BMI
≥30 kg/m2 was the only candidate-related characteristic that increased over
time in all groups. Among programs that were never flagged, the prevalence
of age >60, diabetic and hypertensive nephropathy, PRA ≥80, preemptive
listings, and average zipcode income <$30,000 increased, whereas the
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proportion of candidates that had received a previous transplant declined.
Among programs flagged in multiple PSRs from July 2007 at July 2009 that
returned to compliance, the proportion of newly wait-listed candidates who
were black significantly increased, but the proportion of candidates from low-
income areas, with less than a high school diploma, and living further from the
transplant center decreased. Among programs with ongoing noncompliance,
the proportion of newly wait-listed candidates with private insurance as their
primary insurance type and the percentage with PRA ≥80 percent signifi-
cantly decreased, while the proportion of candidates listed preemptively
increased. Nonsignificant increases in the prevalence of neighborhood income
<$30,000 and lower educational attainment were also observed for the ongo-
ing noncompliance group. The proportion of sensitized candidates (PRA ≥80)
was similar across all flagging groups at 2–1 years pre-first flag (range: 6.2–6.9
percent); however, at 1–2 years post-first flag (or July 2008/July 2009) the
proportion of candidates with PRA ≥80 ranged from 1.8 percent among pro-
grams receiving a single flag between July 2007 and July 2009, to 8.4 percent
among programs flagged in multiple PSRs that returned to compliance
(p < .001). At both 2–1 years pre and 1–2 years post-first flag, the group of
programs with ongoing noncompliance had the highest proportion of candi-
dates with diabetic and hypertensive nephropathy, the lowest proportion with
private insurance as their primary insurance type, the lowest proportion of
candidates preemptively listed for transplantation, the highest proportion
from low-income neighborhoods, and the shortest distance from candidate
ZIP-code to transplant center. In contrast, in both 2005/2006 and 2008/2009,
the group of programs that were never flagged had the lowest proportion of
newly wait-listed candidates that were black, had received a prior transplant,
or had a primary diagnosis of hypertensive nephropathy.
Aggregate trends in risk of 1-year graft failure attributable to donor, reci-
pient, and overall transplant characteristics by program group, for deceased
donor kidney transplants performed over the interval from 2001 and 2011, are
shown in Figure 3. Regression models testing for linear trends in relative risk
of 1-year graft failure over time indicated that the weighted average risk associ-
ated with donor-related factors increased significantly over time among pro-
grams that were never flagged (b = 0.007, p < .0001), programs receiving a
single flag (b = 0.006, p < .0001), and programs that were flagged in multiple
PSRs but returned to compliance (b = 0.003, p = .0008). Average risk associ-
ated with recipient-related factors increased significantly over time among
programs that were never flagged (b = 0.008, p < .0001), programs that were
flagged in multiple PSRs but returned to compliance (b = 0.005, p = .0005),
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programs with ongoing noncompliance (b = 0.0094, p < .0001), but not pro-
grams with a single flag (b = 0.0002, p = .9). Programs with ongoing noncom-
pliance showed a higher burden of risk due to recipient factors, compared
with the other groups of programs, over the majority of this interval. The risk
of 1-year graft failure associated with transplant characteristics overall
increased among programs that were never flagged (b = 0.009, p < .0001),
programs that were flagged on a single occasion (b = 0.007, p = .0016), and
programs with ongoing noncompliance (b = 0.007, p < .0001). In almost all
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Figure 3: Aggregate Risk of One-Year Graft Failure, Relative to the Overall
Risk in 2007, Associated with Donor, Recipient and Overall Transplant Char-
acteristics (Deceased Donor Kidney Transplants)
Aggregate Risk is the Average Risk within EachGroup of Programs,Weighted
for Program Size. The Average Sample Sizes (Average Annual Number of
Transplants, 2001–2011) for Each Group of Programs Were 847 (Single Flag),
995 (Multiple Flags, Returned to Compliance), 1,702 (Ongoing Non-Compli-
ance), and 10,078 (Never Flagged)
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calendar years the overall transplant risk, relative to overall transplant risk in
2007, was lowest for the group of programs that were never flagged.
Sensitivity analyses estimating the unweighted aggregate risks of 1-year
graft failure associated with donor, recipient, and overall transplant factors
yielded similar qualitative trends toward increasing aggregate transplant risks.
The main difference, compared with the weighted analyses, was that there was
less differentiation between the program groups; no one group of programs
showed a consistently higher or lower donor/recipient/transplant-associated
risk than any other group of programs on unweighted analysis.
DISCUSSION
There remains considerable debate in the transplant community as to the
potential trade-offs associated with increased regulation of transplant pro-
grams in terms of organ utilization, transplant volumes, and access to trans-
plantation for higher risk candidates. We found that, since the implementation
of the Medicare CoPs in mid-2007, kidney transplant volumes in the United
States have overall remained steady; however, declines in transplant volume,
in particular ECD transplant volume, were observed for programs with ongo-
ing noncompliance. Risk of 1-year graft failure associated with recipient-
related factors, by comparison, showed a trend toward an increasing burden
of risk over time, both among programs that were never flagged and among
programs with ongoing noncompliance. This trend was driven largely by
increases in the overall proportion of recipients aged >60 years or with a BMI
≥30 kg/m2.
Interestingly, programs with ongoing noncompliance showed a consis-
tently higher aggregate burden of risk due to recipient-related factors
compared with programs with fewer or no outcomes flags. This was predomi-
nantly attributable to a higher prevalence of recipients with hypertensive
nephropathy, diabetes, BMI ≥30 kg/m2, and ESRD duration >2 years in this
group of programs. By contrast, the group of programs that were never
flagged had the lowest aggregate risk of 1-year graft failure due to overall
transplant factors in almost all calendar years from 2001 to 2011. Previous
studies have found that programs serving a high-risk patient population were
more likely to be flagged by SRTR for poor outcomes (Schold et al. 2008). In
addition, a recent analysis of the relationship between community health
indicators and post-transplant outcomes found that the burden of poor
physical and mental health, smoking, obesity, physical inactivity, preventable
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hospital stays, illiteracy, low income, and low birth weight was predictive of
graft and patient survival among transplant recipients resident in that
community (Schold et al. 2012). It may be the case that the health outcomes
of the surrounding population influence outcomes seen in the PSRs, such
that programs serving high-risk communities might be more susceptible to
outcomes flagging. Conversely, the finding of consistently lower aggregate
risk of 1-year graft failure among programs that were never flagged may
suggest selection bias on the part of these programs. It should also be noted,
however, that the higher burden of recipient-related risk among programs
with ongoing noncompliance and the lower overall risk among programs
that were never flagged were observed only in analyses weighted for
program size; therefore, while these findings reflect the national experience
overall, they will not be indicative of the experience of each individual
transplant program.
Although we found little evidence to suggest that transplant programs
have in aggregate reduced their exposure to any of the factors accounted for in
the SRTR risk-adjustment model, we did observe some evidence of reduced
wait-listing of candidates living in low-income neighborhoods among pro-
grams receiving multiple flags that subsequently returned to compliance. The
proportion of newly wait-listed candidates with less than a high school
diploma, and the average distance to the transplant center also declined in this
group. This is likely to be due at least in part to more conservative candidate
selection criteria, based on the belief that socio-economic factors may affect
the ability of the patient to comply with care post-transplant. In contrast,
among programs with ongoing non-compliance the proportions of newly
wait-listed candidates living in low-income neighborhoods or without a high
school diploma both in fact increased. These trends likely reflect some degree
of loss of referrals and changing payer center selection, as private payers have
been using the SRTR PSRs to identify centers of excellence and to discourage
or exclude beneficiaries from selecting programs with poor post-transplant
outcomes. Indeed, programs with multiple flags or ongoing noncompliance
experienced a decline in the proportion of newly listed candidates with private
insurance as their primary insurance type over the interval pre-/post-first
outcomes flag.
Our findings are consistent with a recent study of trends in kidney trans-
plant volumes subsequent to the implementation of the CMS CoPs. Schold
et al. found that programs with 1-year graft or patient survival significantly
lower than expected at least once between January 2007 and July 2009 were
more likely to show a reduction in SCD, ECD and living donor transplant
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volume over time, relative to other programs; however, other than modest
reductions in ECD utilization, cold ischemia time, and private insurance
(none of which were significant in our analysis), the authors did not find evi-
dence that reductions in transplant volume among low-performing centers
were explained by risk-averse practices (Schold et al. 2013). Indeed, in addi-
tion to the loss of privately insured patients, programs under CMS review
may be advised or even mandated to undergo a period of inactivity while
they regroup, and therefore temporary volume loss may in some cases be a
deliberate, rather than unintended, consequence of the CoPs (Hamilton
2013).
Furthermore, it must be noted that the introduction of the Medicare
CoPs occurred at a time when several initiatives and policy revisions had
recently been undertaken to improve access to organ transplantation, poten-
tially influencing transplant volumes and outcomes, and practices with respect
to wait-listing, organ allocation, and recipient selection. The OPTN imple-
mented a range of policies in 2002 intended to maximize the recovery and uti-
lization of ECD kidneys and expedite placement (Metzger et al. 2003). The
Organ Donation Breakthrough Collaborative, launched in 2003, was associ-
ated with an increase in the number of organs donated until the Collaborative
was concluded in 2006 (Howard et al. 2007). The subsequent Organ Trans-
plantation Breakthrough Collaborative, launched in 2005, gave special focus
to improved utilization of ECD and DCD organs (Leichtman et al. 2008). Yet
the number of deceased donors in the United States has not increased since
the end of the Collaborative era, due to some extent to a 15 percent drop in
the number of reported eligible deaths from 2006 to 2009 and a sustained high
rate of organ discard (Wynn and Alexander 2011).Whether, or to what extent,
these trends are driven by the increasing difficulty in placing high-risk organs
is unclear but warrants further investigation. Several of the observed trends
with respect to donor, recipient, and transplant characteristics over the era sur-
rounding the introduction of the CoPs are also likely to be linked to medical
and policy developments immediately prior to the introduction of the CoPs,
such as increased application of pulsatile perfusion preservation (Abboud
et al. 2011), changes to deceased donor kidney allocation policy eliminating
priority based on HLA-B matching (Ashby et al. 2011), and the 2007
introduction of DonorNet (Massie et al. 2009; Gerber et al. 2010). It is there-
fore difficult to isolate evidence of risk-averse practices related to program
performance subsequent to the introduction of the CoPs in the context of
general shifts toward higher risk transplants as well as demographic and
broader epidemiological trends (e.g., increasing rates of obesity).
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The main limitation of our analysis is the inability, in the absence of
qualitative data describing each programs reaction to the introduction of the
CoPs, to describe the exact nature, motivation, or timing behind any implied
changes in individual program practices. Implementation of the Medicare
CoPs officially began in July 2007; however, announcements regarding the
forthcoming CMS regulations were released as early as 2005, and the OPTN
Membership and Professional Standards Committee (MPSC) had adopted
similar methodology several years earlier, with some programs having
already undergone MPSC reviews and site visits. Another limitation of our
analysis is that it was not possible to interrogate all possible criteria by which
programs might select organs and candidates if seeking to minimize their
exposure to risk of adverse transplant outcomes. We evaluated trends for all
components of the SRTR risk-adjustment model, which focuses on factors
shown to have a high probability of being associated with patient or graft
outcomes (Dickinson et al. 2008). However, programs may decide to select
or exclude recipients on the basis of a wider set of comorbidities not
included in risk adjustment models but shown to predict graft failure, such
as cardiac disease, neurological disease, anemia or fluid, and electrolyte
disorders (Weinhandl et al. 2009), or more subjective factors such as socio-
economic disadvantage and associated expectations concerning patient
adherence.
We observed a decline in transplant volumes, particularly ECD vol-
umes, for the subgroup of adult kidney transplant programs that experienced
ongoing noncompliance subsequent to the introduction of theMedicare CoPs.
While we did not observe evidence of programs systematically reducing their
exposure to risk factors accounted for in SRTR risk adjustment models, we
did observe some evidence of greater selectivity with respect to socio-eco-
nomic factors among programs with multiple flags that returned to compli-
ance. A detailed qualitative evaluation of responses to the regulations at the
program level would clarify these findings.
ACKNOWLEDGMENTS
Joint Acknowledgment/Disclosure Statement: This research was supported through
a contract from the Centers for Medicare and Medicaid Services: CMS con-
tract no. 500-2011-00091C.
Disclosures: None.
Disclaimer: None.
348 HSR: Health Services Research 50:2 (April 2015)
REFERENCES
Abboud, I., C. Antoine, F. Gaudez, F. Fieux, C. Lefaucheur, E. Pillebout, D. Viglietti,
T. Serrato, J. Verine, M. Flamant, M. N. Peraldi, and D. Glotz. 2011. “Pulsatile
Perfusion Preservation for Expanded-Criteria Donors Kidneys: Impact on
DelayedGraft Function Rate.” International Journal of Artificial Organs 34 (6): 513–8.
Abecassis, M. M., R. Burke, G. B. Klintmalm, A. J. Matas, R. M. Merion, D. Millman,
K. Olthoff, and J. P. Roberts. 2009. “American Society of Transplant Surgeons
Transplant Center Outcomes Requirements–A Threat to Innovation.” American
Journal of Transplantation 9 (6): 1279–86.
Ashby, V. B., F. K. Port, R. A. Wolfe, J. J. Wynn, W. W. Williams, J. P. Roberts, and A.
B. Leichtman. 2011. “Transplanting Kidneys without Points for HLA-B Match-
ing: Consequences of the Policy Change.” American Journal of Transplantation 11
(8): 1712–8.
Axelrod, D. A. 2013. “Balancing Accountable Care with Risk Aversion: Transplanta-
tion as aModel.” American Journal of Transplantation 13 (1): 7–8.
Centers forMedicare andMedicaid Services. 2007. “Hospital Conditions of Participation:
Requirements for Approval and Re-Approval of Transplant Centers To Perform
Organ Transplants; Final Rule.” 42 CFR Parts 405, 482, 488 and 498 Medicare
Programs. Department of Health &Human Services. Federal Register.
Dickinson, D. M., C. J. Arrington, G. Fant, G. N. Levine, D. E. Schaubel, T. L. Pruett,
M. S. Roberts, and R. A.Wolfe. 2008. “SRTR Program-Specific Reports on Out-
comes: A Guide for the New Reader.” American Journal of Transplantation 8 (4 Pt
2): 1012–26.
Gerber, D. A., C. J. Arrington, S. E. Taranto, T. Baker, and R. S. Sung. 2010. “Donor-
Net and the Potential Effects on Organ Utilization.” American Journal of Transplan-
tation 10 (4 Pt 2): 1081–9.
Hamilton, T. E. 2008. “Improving Organ Transplantation in the United States — a
Regulatory Perspective.” American Journal of Transplantation 8 (12): 2503–5.
———————. 2013. “Regulatory Oversight in Transplantation: Are the Patients Really Better
Off?”Current Opinion in Organ Transplantation 18 (2): 203–9.
Howard, R. J., D. L. Cornell, and J. D. Schold. 2009. “CMS Oversight, OPOs and
Transplant Centers and the Law of Unintended Consequences.” Clinical Trans-
plantation 23 (6): 778–83.
Howard, D. H., L. A. Siminoff, V. McBride, andM. Lin. 2007. “Does Quality Improve-
ment Work? Evaluation of the Organ Donation Breakthrough Collaborative.”
Health Services Research 42 (6, Part I): 2160–73.
Leichtman, A. B., D. Cohen, D. Keith, K. O’Connor, M. Goldstein, V. McBride, C. J.
Gould, L. L. Christensen, and V. B. Ashby. 2008. “Kidney and Pancreas
Transplantation in the United States, 1997-2006: The HRSA Breakthrough Col-
laboratives and the 58 DSA Challenge.” American Journal of Transplantation 8 (4
Pt 2): 946–57.
Massie, A. B., S. L. Zeger, R. A. Montgomery, and D. L. Segev. 2009. “The Effects of
DonorNet 2007 on Kidney Distribution Equity and Efficiency.” American Journal
of Transplantation 9 (7): 1550–7.
Regulation and Transplant Program Practices 349
Metzger, R. A., F. L. Delmonico, S. Feng, F. K. Port, J. J. Wynn, and R. M. Merion.
2003. “Expanded Criteria Donors for Kidney Transplantation.” American Journal
of Transplantation 3 (Suppl 4): 114–25.
Organ Procurement and Transplant Network (OPTN). 2012. “A Guide to Calculating
and Interpreting the Kidney Donor Profile Index (KDPI)” [accessed on Decem-
ber 7, 2012]. Available at http://optn.transplant.hrsa.gov/ContentDocuments/
Guide_to_Calculating_Interpreting_KDPI.pdf
Port, F. K., J. L. Bragg-Gresham, R. A. Metzger, D. M. Dykstra, B. W. Gillespie, E. W.
Young, F. L. Delmonico, J. J. Wynn, R. M. Merion, R. A. Wolfe, and P. J. Held.
2002. “Donor Characteristics Associated with Reduced Graft Survival: An
Approach to Expanding the Pool of Kidney Donors.” Transplantation 74 (9):
1281–6.
Schold, J. D., C. J. Arrington, and G. Levine. 2010. “Significant Alterations in Reported
Clinical Practice Associated with Increased Oversight of Organ Transplant Cen-
ter Performance.” Progress in Transplantation 20 (3): 279–87.
Schold, J. D., T. R. Srinivas, R. J. Howard, I. R. Jamieson, and H. U. Meier-Kriesche.
2008. “The Association of Candidate Mortality Rates with Kidney Transplant
Outcomes and Center Performance Evaluations.” Transplantation 85 (1): 1–6.
Schold, J. D., L. D. Buccini, M. W. Kattan, D. A. Goldfarb, S. M. Flechner, T. R.
Srinivas, E. D. Poggio, R. Fatica, L. K. Kayler, and A. R. Sehgal. 2012.
“The Association of Community Health Indicators with Outcomes for
Kidney Transplant Recipients in the United States.” Archives of Surgery 147 (6):
520–6.
Schold, J. D., L. D. Buccini, T. R. Srinivas, R. T. Srinivas, E. D. Poggio, S. M. Flechner,
C. Soria, D. L. Segev, J. Fung, and D. A. Goldfarb. 2013. “The Association of
Center Performance Evaluations and Kidney Transplant Volume in the United
States.” American Journal of Transplantation 13 (1): 67–75.
Scientific Registry of Transplant Recipients (SRTR). 2012. “Risk Model Documenta-
tion” [accessed on December 7, 2012]. Available at http://www.srtr.org/csr/cur-
rent/Centers/201206/modtabs/Risk/KIADC2G.pdf
Weinhandl, E. D., J. J. Snyder, A. K. Israni, and B. L. Kasiske. 2009. “Effect of Comor-
bidity Adjustment on CMS Criteria for Kidney Transplant Center Perfor-
mance.” American Journal of Transplantation 9 (3): 506–16.
Wynn, J. J., and C. E. Alexander. 2011. “Increasing Organ Donation and Transplanta-
tion: The U.S. Experience over the Past Decade.” Transplant International 24 (4):
324–32.
SUPPORTING INFORMATION
Additional supporting information may be found in the online version of this
article:
Appendix SA1: AuthorMatrix.
350 HSR: Health Services Research 50:2 (April 2015)
